"The Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry."
So a single device company which is struggling to explain to market why it is not achieving sales does not think external validation of one of highest risks of the product - design quality and fit for purpose - is new worthy.
Kyahn, if you are reading this, please re-think informing investors of this premier award. There are plenty of similar announcements from other ASX listed companies.
"The Medical Design Excellence Awards (MDEA) is the premier...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
-0.001(25.0%) |
Mkt cap ! $5.824M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.2¢ | 0.1¢ | $6.001K | 5.059M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 41585905 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 83677901 | 59 |
View Market Depth
| Last trade - 15.59pm 03/12/2024 (20 minute delay) ? |
| AXP (ASX) Chart |
